explore -WSS

explore

author：explore 2025-10-01 22:50:11 - browse：7

A psilocybin mushroom lays inside a clear capsule — Adobe

A single dose of psilocybin may have enduring benefits for people with major depressive disorder, according to a randomized clinical trial published Thursday in the Journal of the American Medical Association.

Several prior studies have suggested that psilocybin, the psychedelic compound produced by certain types of mushrooms, could be a promising way to treat major depression in people for whom antidepressants or counseling aren’t effective. But those studies mostly focused on short-term results, while the new JAMA study looked at psilocybin’s efficacy up to six weeks after the administration of a single dose of psilocybin.

“It’s exciting to see another study that’s coming out that is adding to the evidence base suggesting potential efficacy of psilocybin for depression, amongst other conditions,” said Greg Fonzo, an assistant professor and co-director for the Center for Psychedelic Research and Therapy at the University of Texas at Austin’s Dell Medical School, who was not involved in the study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Take antibiotics after sex, CDC recommends for certain risk groups

explore

WSS

Plane’s emergency slide plummets from sky, hits Chicago home

Senators tussle over abortion against the backdrop of a presidential campaign

STAT wants to know your pick for a great summer read or listen

DOJ, FTC to increase scrutiny of all types of health care mergers

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

Take antibiotics after sex, CDC recommends for certain risk groups

focus

explore

Wikipedia

The high cost of giving birth even with insurance

FDA approves Moderna’s RSV vaccine, its second licensed product

BioMarin wins approval for gene therapy to treat hemophilia A

Stanford updates investigation of president’s past research

Duchenne breakthrough therapy leaves behind pioneering families

The most pressing bird flu mysteries scientists want answered

After affirmative action ruling, medical educators look to 'holistic review'

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Lindsay Lohan welcomes 1st child with husband Bader Shammas

hotspot

Data don't support strong claims for Covid

'Little Tech' descents on D.C., wanting a say in how AI is regulated

UnitedHealth CEO's Medicaid comments send insurer stocks diving

A new initiative will help leaders fight the next pandemic

FDA approves Moderna’s RSV vaccine, its second licensed product

Why the Crimean Bridge is key to Russia's war in Ukraine

Wikipedia

explore

leisure time

hotspot